<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/EDC7316F-A897-4CBC-BA1F-30CE73C9FEFD"><gtr:id>EDC7316F-A897-4CBC-BA1F-30CE73C9FEFD</gtr:id><gtr:name>Astellas Pharma</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Biochemistry</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EDC7316F-A897-4CBC-BA1F-30CE73C9FEFD"><gtr:id>EDC7316F-A897-4CBC-BA1F-30CE73C9FEFD</gtr:id><gtr:name>Astellas Pharma</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8F27F83F-F830-4172-B687-6D7C1E69BB1F"><gtr:id>8F27F83F-F830-4172-B687-6D7C1E69BB1F</gtr:id><gtr:firstName>Jeremy</gtr:firstName><gtr:surname>Tavare</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G7708269"><gtr:id>5F4616F7-106F-4750-BF52-D9E28CA74036</gtr:id><gtr:title>Studies on the Molecular Mechanism of Insulin Action</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G7708269</gtr:grantReference><gtr:abstractText>Diabetes and obesity represent an enormous public health problem that is set to increase substantially over the next decade placing even further strain on a limited health budget. While education will play an important role in reducing their incidence, pharmaceutical intervention will remain a very important method of treatment until methods of beta cell transplantation improve (e.g. stem cells), and/or public attitudes towards diet and exercise change. Indeed, the importance that is placed on diabetes research was exemplified by the ?Department of Health and MRC Review on Diabetes Research? which was published in 2002 as part of the National Service Framework for Diabetes.

One of the most important actions of insulin is to stimulate the uptake of glucose from the blood into muscle and fat tissue. In type I diabetes, insulin is not produced due to auto-immune attack on the beta cells which are responsible for insulin production. In type II diabetes, insulin production is often normal or elevated (until late stage diabetes) but the target tissues for insulin action do not respond effectively (?insulin resistance?). While we have an increasing understanding of how insulin works on glucose uptake, many aspects are still completely unknown. For example, we know that an enzyme called protein kinase B (PKB) is involved but we do not know in exactly what capacity and how this may be affected in diabetes. Our work involves using a unique combination of state-of-the-art cell and molecular biology techniques as well as proteomics to examine the mechanism by which insulin brings about its effects on glucose uptake with particular emphasis on the role of PKB. 

We take public engagement and dialogue extremely seriously. Professor Tavare was recently part of a programme broadcast on the BBC called ?Cell City? which examined the inner workings of cells. The programme was part of the Open University?s Open Science series and he discussed our work using green fluorescent protein to follow the dynamics of insulin action inside single living cells. Professor Tavare has also appeared on both HTV and BBC local news programmes and has given a number of lay presentations at Diabetes UK Regional Groups (including Swindon, Bournemouth and London). Two members of the research team are part of the Bristol Teacher-Scientist Partnership Network and have taken part in primary and secondary school science education.</gtr:abstractText><gtr:technicalSummary>The stimulation of the translocation of the insulin responsive glucose transporter, GLUT4, from intracellular storage locations to the plasma membrane underlies the ability of insulin to increase glucose uptake. Our principal objective is to define the molecular basis by which insulin stimulates glucose transport in adipocytes, specifically the signalling mechanism employed. A complete molecular explanation of this action of insulin is crucial to uncovering new drug targets for potential therapeutic intervention in both types I and II diabetes. 

There is substantial evidence to suggest that the activation of protein kinase B (PKB) is central to the action of insulin on glucose transport, although the substrate proteins involved have not been identified. In the current proposal we plan to delineate the precise role that PKB plays in this action of insulin, and to purify, identify and characterise the critical PKB substrate(s) involved. We have recently identified a phosphoinositide 5-kinase, PIKfyve, as a potentially important PKB substrate in primary adipocytes. We plan to investigate whether this enzyme plays a role in GLUT4 trafficking.

An important aspect of insulin action on glucose uptake is the compartmentalisation of signalling proteins, including PKB. We will develop genetically-encoded fluorescent biosensors for PKB activity, to examine the kinetics of PKB activation in specific intracellular compartments (e.g. on the surface of GLUT4 vesicles and endosomes) such that we can relate this to the stimulation of GLUT4 translocation. Furthermore, we will develop novel fluorescence-based methods for studying the interaction between selected signalling molecules involved in insulin action on GLUT4 translocation (IRS and PI3-kinase, in the first instance), and investigate the intracellular compartments within which these interactions occur.

In parallel, we will take advantage of recent major developments in time-lapse microscopy and GFP technologies to follow the dynamics of GFP-labelled GLUT4 vesicles. Our recent studies suggest that insulin may induce a re-distribution of GLUT4 to the plasma membrane either by initiating a budding event from relatively static peripheral GLUT4 vesicles, or by transit through a tubular vesicular network. The extent to which these events involve PKB will be investigated.</gtr:technicalSummary><gtr:fund><gtr:end>2008-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1978-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>4256301</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Investigations into the efficacy of IGF1R kinase inhibitors towards IGF1 and insulin signalling</gtr:description><gtr:id>FA76A3C9-5FC0-4F70-8CF2-4024EE880BDD</gtr:id><gtr:impact>Studies ongoing but publication in preparation</gtr:impact><gtr:partnerContribution>Increased our understanding of the contribution of insulin action to tumorigenesis</gtr:partnerContribution><gtr:piContribution>Studies ongoing</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Astellas Pharma</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Prosidion Ltd</gtr:department><gtr:description>Insulin action in human adipocytes</gtr:description><gtr:id>3BF90EB5-1EDE-448D-B9DE-B61FCA0024CA</gtr:id><gtr:impact>Support for a BBSRC/CASE student</gtr:impact><gtr:partnerContribution>Support for a BBSRC/CASE student</gtr:partnerContribution><gtr:piContribution>We are currently undertaking research into this topic.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>How insulin works</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9F65785C-A704-40AF-B5A8-347C116FAC5A</gtr:id><gtr:impact>Presentation to local diabetes fund raising groups and to a schools (year 6)

Public education</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HTV West</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E66B0C9F-9500-422E-8DD2-C489CCF1C787</gtr:id><gtr:impact>ITV interview

Public education</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Radio</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>DC87AB66-35D6-4282-9809-876874C55313</gtr:id><gtr:impact>BBC Radio interview

Public education</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>169906</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes UK, Project Grant</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>9EF7E71D-5948-4EF1-9A04-5052E9B229C5</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2814340</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Seeding Drug Discovery Award</gtr:description><gtr:end>2008-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A95DC766-C3C1-4B29-A5EE-5D0B7061F9F6</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>501000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Capacity Building Studentship</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>1E2EF472-FCC1-484F-863C-FC1C3BBFE832</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>240000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Project Grant</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>AABFCD6F-0E88-4B2F-8B55-C9FC3E734CA7</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>420000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC DPFS Award (devolved portfolio)</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D7388619-4637-4F34-8FE6-F7955F240306</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>705000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Fellowship</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D4E006AB-2A01-46DF-BEA2-9A0BA57C778D</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes UK, PhD Studentship</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>5A5CC939-E508-462F-B183-294D556528B9</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Various GFP tagged proteins for use in cell biology research</gtr:description><gtr:id>2F5280D5-5E5E-4328-9B42-F8CED88EAAB2</gtr:id><gtr:impact>Several publications</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>GFP tagged proteins</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7560793F-ED3D-461B-8389-0E2BB7292B1D"><gtr:id>7560793F-ED3D-461B-8389-0E2BB7292B1D</gtr:id><gtr:title>The molecular basis of insulin-stimulated glucose uptake: signalling, trafficking and potential drug targets.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cc274db7d119df86d438843dc2cd5279"><gtr:id>cc274db7d119df86d438843dc2cd5279</gtr:id><gtr:otherNames>Leney SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D8390FC4-FF85-4439-8E2B-9A3698E7C2D7"><gtr:id>D8390FC4-FF85-4439-8E2B-9A3698E7C2D7</gtr:id><gtr:title>Identification of a novel signaling pathway and its relevance for GluA1 recycling.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ce524e9b511c8127a0ec8dc77dfd9c0d"><gtr:id>ce524e9b511c8127a0ec8dc77dfd9c0d</gtr:id><gtr:otherNames>Seebohm G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/359C7D87-8BAC-4E85-B78B-56580C5EC2CF"><gtr:id>359C7D87-8BAC-4E85-B78B-56580C5EC2CF</gtr:id><gtr:title>An intracellular motif of GLUT4 regulates fusion of GLUT4-containing vesicles.</gtr:title><gtr:parentPublicationTitle>BMC cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f758173a2a6188500bd8f97a8c746e16"><gtr:id>f758173a2a6188500bd8f97a8c746e16</gtr:id><gtr:otherNames>Heyward CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-2121</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BEC2BA87-363C-417F-81E1-95425D1A4C88"><gtr:id>BEC2BA87-363C-417F-81E1-95425D1A4C88</gtr:id><gtr:title>PIKfyve upregulates CFTR activity.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0220f233fbfa90db50f4dfb7a9a49ab2"><gtr:id>0220f233fbfa90db50f4dfb7a9a49ab2</gtr:id><gtr:otherNames>Gehring EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C71C1A92-88FB-455F-AD54-FEB026874F01"><gtr:id>C71C1A92-88FB-455F-AD54-FEB026874F01</gtr:id><gtr:title>Nucleo-cytosolic shuttling of FoxO1 directly regulates mouse Ins2 but not Ins1 gene expression in pancreatic beta cells (MIN6).</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/407faeb2957ad2b98f5f836665657ed3"><gtr:id>407faeb2957ad2b98f5f836665657ed3</gtr:id><gtr:otherNames>Meur G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/23BC427B-A0D9-413E-8B73-086D9A2526B2"><gtr:id>23BC427B-A0D9-413E-8B73-086D9A2526B2</gtr:id><gtr:title>Regulation of the Na(+), glucose cotransporter by PIKfyve and the serum and glucocorticoid inducible kinase SGK1.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a51abc65516cc004b09a7ffbbaee9d32"><gtr:id>a51abc65516cc004b09a7ffbbaee9d32</gtr:id><gtr:otherNames>Shojaiefard M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A064B738-9F09-49E9-A7DE-534A2D66FDDC"><gtr:id>A064B738-9F09-49E9-A7DE-534A2D66FDDC</gtr:id><gtr:title>Regulation of the Na(+)-coupled glutamate transporter EAAT3 by PIKfyve.</gtr:title><gtr:parentPublicationTitle>Neurochemistry international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a7b25ed8dbed6ab2fade2003145340cb"><gtr:id>a7b25ed8dbed6ab2fade2003145340cb</gtr:id><gtr:otherNames>Klaus F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0197-0186</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CB96A792-1524-4034-B10B-F919205592F9"><gtr:id>CB96A792-1524-4034-B10B-F919205592F9</gtr:id><gtr:title>Altered stress stimulation of inward rectifier potassium channels in Andersen-Tawil syndrome.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ce524e9b511c8127a0ec8dc77dfd9c0d"><gtr:id>ce524e9b511c8127a0ec8dc77dfd9c0d</gtr:id><gtr:otherNames>Seebohm G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E92DF91B-C50A-42FC-BB40-E431764F45A2"><gtr:id>E92DF91B-C50A-42FC-BB40-E431764F45A2</gtr:id><gtr:title>Rip11 is a Rab11- and AS160-RabGAP-binding protein required for insulin-stimulated glucose uptake in adipocytes.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/805179816d91beda61a61852177a06e4"><gtr:id>805179816d91beda61a61852177a06e4</gtr:id><gtr:otherNames>Welsh GI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/51BBA3F9-5650-4271-959D-0252C78B1176"><gtr:id>51BBA3F9-5650-4271-959D-0252C78B1176</gtr:id><gtr:title>Imaging of insulin signaling in skeletal muscle of living mice shows major role of T-tubules.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6edfe77931433cfe95b45ba2c863c596"><gtr:id>6edfe77931433cfe95b45ba2c863c596</gtr:id><gtr:otherNames>Lauritzen HP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/576FDCEA-419A-442B-BA12-A3A661AC8BEE"><gtr:id>576FDCEA-419A-442B-BA12-A3A661AC8BEE</gtr:id><gtr:title>Regulation of the glutamate transporter EAAT2 by PIKfyve.</gtr:title><gtr:parentPublicationTitle>Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0220f233fbfa90db50f4dfb7a9a49ab2"><gtr:id>0220f233fbfa90db50f4dfb7a9a49ab2</gtr:id><gtr:otherNames>Gehring EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1015-8987</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1ABF11CB-157A-4271-8DD2-2EEBD214A5FD"><gtr:id>1ABF11CB-157A-4271-8DD2-2EEBD214A5FD</gtr:id><gtr:title>Regulation of endocytic recycling of KCNQ1/KCNE1 potassium channels.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ce524e9b511c8127a0ec8dc77dfd9c0d"><gtr:id>ce524e9b511c8127a0ec8dc77dfd9c0d</gtr:id><gtr:otherNames>Seebohm G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/49135DDC-926D-4798-8C37-A3D02C8A266D"><gtr:id>49135DDC-926D-4798-8C37-A3D02C8A266D</gtr:id><gtr:title>Regulation of small GTP-binding proteins by insulin.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/805179816d91beda61a61852177a06e4"><gtr:id>805179816d91beda61a61852177a06e4</gtr:id><gtr:otherNames>Welsh GI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A4B8507D-BC16-4336-9707-6E4BE4A51AF0"><gtr:id>A4B8507D-BC16-4336-9707-6E4BE4A51AF0</gtr:id><gtr:title>Regulation of the glutamate transporter EAAT4 by PIKfyve.</gtr:title><gtr:parentPublicationTitle>Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a3c7b9c9c9572b964628a5eb7e57eb93"><gtr:id>a3c7b9c9c9572b964628a5eb7e57eb93</gtr:id><gtr:otherNames>Alesutan IS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1015-8987</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/979C977C-89EC-428F-B56B-410E1BCFC9C5"><gtr:id>979C977C-89EC-428F-B56B-410E1BCFC9C5</gtr:id><gtr:title>Identification of p122RhoGAP (deleted in liver cancer-1) Serine 322 as a substrate for protein kinase B and ribosomal S6 kinase in insulin-stimulated cells.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/752acb7d00310cd4227bea9050758b5f"><gtr:id>752acb7d00310cd4227bea9050758b5f</gtr:id><gtr:otherNames>Hers I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4537F65D-473D-4A4A-869A-5E695F226296"><gtr:id>4537F65D-473D-4A4A-869A-5E695F226296</gtr:id><gtr:title>Long QT syndrome-associated mutations in KCNQ1 and KCNE1 subunits disrupt normal endosomal recycling of IKs channels.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ce524e9b511c8127a0ec8dc77dfd9c0d"><gtr:id>ce524e9b511c8127a0ec8dc77dfd9c0d</gtr:id><gtr:otherNames>Seebohm G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F9EEB028-4073-4871-8DB5-52E6D72C3B18"><gtr:id>F9EEB028-4073-4871-8DB5-52E6D72C3B18</gtr:id><gtr:title>Phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) is an AMPK target participating in contraction-stimulated glucose uptake in skeletal muscle.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d7c92a675b6502a97a707b04cca69bc1"><gtr:id>d7c92a675b6502a97a707b04cca69bc1</gtr:id><gtr:otherNames>Liu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7A63CF12-4561-475E-AE8C-87C107FAA547"><gtr:id>7A63CF12-4561-475E-AE8C-87C107FAA547</gtr:id><gtr:title>Regulation of PIKfyve phosphorylation by insulin and osmotic stress.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a3e004cc844ce04d682be3b3d3291685"><gtr:id>a3e004cc844ce04d682be3b3d3291685</gtr:id><gtr:otherNames>Hill EV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G7708269</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>